Omnicell, Inc. (OMCL): Price and Financial Metrics


Omnicell, Inc. (OMCL): $139.83

0.03 (+0.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

OMCL POWR Grades


  • OMCL scores best on the Growth dimension, with a Growth rank ahead of 98.57% of US stocks.
  • The strongest trend for OMCL is in Growth, which has been heading up over the past 199 days.
  • OMCL's current lowest rank is in the Stability metric (where it is better than 54.05% of US stocks).

OMCL Stock Summary

  • With a price/earnings ratio of 172.5, OMNICELL Inc P/E ratio is greater than that of about 95.42% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for OMCL is currently 27.7, higher than 80.82% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of 959.92%, OMNICELL Inc's debt growth rate surpasses 98.22% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to OMNICELL Inc are HCKT, STMP, VERU, MOMO, and APPS.
  • OMCL's SEC filings can be seen here. And to visit OMNICELL Inc's official web site, go to www.omnicell.com.

OMCL Price Target

For more insight on analysts targets of OMCL, see our OMCL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $140.13 Average Broker Recommendation 1.5 (Moderate Buy)

OMCL Stock Price Chart Interactive Chart >

Price chart for OMCL

OMCL Price/Volume Stats

Current price $139.83 52-week high $146.99
Prev. close $139.80 52-week low $56.16
Day low $136.66 Volume 224,400
Day high $140.12 Avg. volume 390,714
50-day MA $135.26 Dividend yield N/A
200-day MA $105.26 Market Cap 6.04B

Omnicell, Inc. (OMCL) Company Bio


Omnicell provides automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. The company was founded in 1992 and is based in Mountain View, California.

OMCL Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$139.83$100.31 -28%

Below please find a table outlining a discounted cash flow forecast for OMCL, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that OMNICELL Inc ranked in the 46th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of OMNICELL Inc, consider:

  • The compound growth rate in the free cash flow of OMNICELL Inc over the past 5.75 years is 0.34%; that's higher than 67.76% of free cash flow generating stocks in the Technology sector.
  • The business' balance sheet suggests that 7% of the company's capital is sourced from debt; this is greater than just 24.42% of the free cash flow producing stocks we're observing.
  • OMNICELL Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-30%
1%-29%
2%-28%
3%-28%
4%-27%
5%-26%

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as OMCL, try CPSI, ACN, BABA, FIS, and OSIS.


OMCL Latest News Stream


Event/Time News Detail
Loading, please wait...

OMCL Latest Social Stream


Loading social stream, please wait...

View Full OMCL Social Stream

Latest OMCL News From Around the Web

Below are the latest news stories about OMNICELL Inc that investors may wish to consider to help them evaluate OMCL as an investment opportunity.

Results: Omnicell, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Omnicell, Inc. ( NASDAQ:OMCL ) defied analyst predictions to release its quarterly results, which were ahead of market...

Yahoo | May 2, 2021

Omnicell, Inc. (OMCL) CEO Randall Lipps on Q1 2021 Results - Earnings Call Transcript

Omnicell, Inc. (OMCL) Q1 2021 Earnings Conference Call April 29, 2021, 04:30 PM ET Company Participants Kathleen Nemeth - VP, IR Randall Lipps - Founder, Chairman, President and CEO Scott Seidelmann - EVP and Chief Commercial Officer Peter Kuipers - CFO Conference Call Participants Iris Long - Bearing Bird Capital...

SA Transcripts on Seeking Alpha | May 1, 2021

Omnicell (OMCL) Q1 Earnings Beat Estimates, Margins Expand

Omnicell's (OMCL) raises adjusted EPS guidance for 2021 , which buoys optimism.

Yahoo | April 30, 2021

Dow Jones Futures Fall: Amazon Flashes Buy Sign But Apple Suppliers, Nio, Twitter Lead Earnings Losers

After a whipsaw Thursday, Amazon popped on blowout earnings. But Apple chipmaker Skyworks sold off. Nio fell.

Yahoo | April 30, 2021

Omnicell Inc (OMCL) Q1 2021 Earnings Call Transcript

On the call, with me today, are Randall Lipps, Omnicell's Chairman, President, CEO and Founder; Scott Seidelmann, Executive Vice President and Chief Commercial Officer; and Peter Kuipers, Executive Vice President and Chief Financial Officer. This call will include forward-looking statements subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied.

Yahoo | April 30, 2021

Read More 'OMCL' Stories Here

OMCL Price Returns

1-mo 6.14%
3-mo 9.04%
6-mo 52.37%
1-year 91.39%
3-year 201.68%
5-year 344.05%
YTD 16.51%
2020 46.87%
2019 33.44%
2018 26.27%
2017 43.07%
2016 9.07%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8023 seconds.